Supernus Pharmaceuticals Inc. logo

Supernus Pharmaceuticals Inc.

SUPN | NASDAQ
Chart Builder DCF Calculator
$43.61
+$0.83 (+1.94%)
Sep 22, 2026, 10:37 AM ET · Market open
TTM
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
830.44M 776.83M 718.95M 681.54M 665.13M 668M 661.82M 651.97M 630.16M 597.4M 607.52M 610.54M 634.01M 668.5M 667.24M 658.96M 630.07M 601.35M 579.78M 564.28M 570.95M 556.35M
Cost of Revenue
99.03M 82.19M 74.56M 77.65M 76.27M 77.36M 77.91M 71.44M 73.45M 76.63M 83.78M 87.11M 93.38M 92.75M 87.22M 81.26M 73.47M 78.04M 75.06M 76.6M 79.9M 63.26M
Gross Profit
731.41M 694.64M 644.39M 603.89M 588.85M 590.64M 583.91M 580.54M 556.71M 520.77M 523.74M 523.43M 540.63M 575.75M 580.02M 577.7M 556.6M 523.31M 504.71M 487.68M 491.05M 493.09M
Operating Income
-111.81M -41.71M -44.52M -36.94M 64.14M 74.56M 81.67M 59.27M 26.56M -13.6M -5.27M 30.06M 20.4M 49.33M 46.12M 17.89M 52.02M 74.78M 86.03M 122.93M 146.47M 157.9M
Interest Income
9.31M 11.21M 13.25M 16.21M 18.03M 17.23M 16.2M 13.21M 10.87M 8.5M 10.45M 10.87M 11.92M 12.34M 21.69M 21.18M 20.65M 21.46M 10.57M 14.4M 14.78M 16.34M
Pretax Income
-123.47M -49.15M -49.03M -20.73M 82.16M 91.8M 97.87M 72.48M 37.42M -6.01M 2.77M 36.92M 26.59M 55.04M 60.74M 27.65M 57.06M 76.97M 73.18M 110.82M 134.57M 150.54M
Net Income
-109.89M -29.02M -38.55M -19.12M 64.5M 61.91M 73.87M 59.71M 5.24M -15.51M 1.32M 25.62M 43.35M 52.04M 60.71M 37.67M 57.49M 73.35M 53.42M 81.75M 100.19M 111.13M
Selling & General & Admin
560.88M 520.79M 485.56M 442.58M 332.66M 325.01M 321.58M 323.46M 336.4M 337.28M 336.36M 329.05M 358.67M 372.36M 377.22M 404.98M 364.7M 333.76M 304.76M 259.32M 241.75M 220.32M
Research & Development
126.09M 118.75M 106.24M 107.06M 106.73M 110.79M 108.8M 103.5M 97.12M 95.31M 91.59M 86.02M 82.92M 74.93M 74.55M 77.86M 77.96M 77.03M 90.47M 87.33M 84.51M 91.3M
Other Expenses
157.14M 97.71M 97.12M 91.19M 85.34M 80.27M 71.87M 94.32M 96.64M 101.78M 101.06M 78.3M 78.64M 79.13M 82.12M 76.97M 61.93M 37.74M 23.46M 18.1M 18.32M 23.57M
Operating Expenses
844.11M 737.24M 688.91M 640.83M 524.72M 516.07M 502.25M 521.27M 530.15M 534.37M 529.01M 493.37M 520.23M 526.41M 533.89M 559.81M 504.59M 448.53M 418.69M 364.75M 344.59M 335.19M
Interest Expense
2.32M n/a n/a n/a n/a n/a n/a n/a n/a 910K 2.42M 4.01M 5.73M 6.63M 7.07M 11.41M 15.61M 19.27M 23.42M 23.59M 23.75M 24.1M
Selling & Marketing Expenses
253.03M 225.37M 288.65M 260.06M 237.33M 231M 227.29M 227.98M 230.43M 231.52M 229.19M 221.9M 250.82M 264.51M 267.79M 281.98M 246.98M 221.78M 199.71M 174.12M 161.55M 141.77M
Cost & Expenses
942.25M 818.54M 763.48M 718.48M 600.99M 593.43M 580.15M 592.71M 603.61M 611M 612.79M 580.47M 613.61M 619.16M 621.11M 641.07M 578.06M 526.57M 493.75M 441.35M 424.49M 398.45M
Income Tax Expense
-13.58M -20.13M -10.48M -1.62M 17.67M 29.88M 24.01M 12.77M 32.19M 9.5M 1.45M 11.3M -16.76M 2.99M 32K -10.02M -427K 3.62M 19.75M 29.07M 34.38M 39.42M
Shares Outstanding (Basic)
58.07M 57.65M 57.34M 56.4M 56.02M 55.86M 55.47M 55.15M 54.98M 54.8M 54.57M 54.61M 54.5M 54.38M 54.1M 53.79M 53.43M 53.33M 53.24M 53.19M 53.01M 52.93M
Shares Outstanding (Diluted)
58.07M 57.65M 57.34M 56.55M 56.64M 55.86M 56.46M 56.02M 55.72M 55.63M 55.06M 54.61M 54.5M 62.45M 62.09M 55.03M 61.4M 61.41M 54.53M 54.33M 54.72M 54.2M
EPS (Basic)
-1.92 -0.51 -0.68 -0.33 1.17 1.13 1.34 1.08 0.09 -0.29 0.02 0.47 0.79 0.96 1.13 0.71 1.09 1.39 1.02 1.55 1.90 2.11
EPS (Diluted)
-1.92 -0.51 -0.68 -0.34 1.15 1.11 1.32 1.07 0.09 -0.29 0 0.41 0.73 0.89 1.03 0.64 1.01 1.30 0.98 1.51 1.85 2.07
EBITDA
-15.87M 51.75M 49.34M 67.89M 166.09M 166.99M 165.71M 143.14M 109.85M 75.42M 90.04M 124.96M 116.27M 146.45M 153.36M 116.47M 134.97M 143.6M 129.19M 159.81M 184.89M 197.64M
EBIT
-117.58M -45.58M -42.23M -17.5M 85.4M 86.94M 85.29M 59.9M 24.85M -9.59M 5.18M 40.93M 32.32M 61.67M 67.81M 39.06M 72.67M 96.24M 96.6M 134.4M 158.32M 174.64M
Depreciation & Amortization
101.71M 97.32M 91.56M 85.39M 80.69M 80.05M 80.41M 83.25M 85M 85.01M 84.86M 84.03M 83.95M 84.78M 85.54M 77.4M 62.3M 47.37M 32.6M 25.41M 26.58M 23M

© 2026 bestshares.com. All rights reserved.